UPDATE: Morgan Stanley Reiterates On WuXi PharmaTech On Long-Term Investment
May 15, 2014 at 09:15 AM EDT
In a report published Thursday, Morgan Stanley analyst Bin Li reiterated an Overweight rating on WuXi PharmaTech (NYSE: WX), but removed ...